Related Experiment Video

Updated: Jul 4, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

RNASET2 as a tumor antagonizing gene in a melanoma cancer model

Laura Monti1, Monica Rodolfo, Monica Rudolfo

  • 1Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy.

Oncology Research
|June 12, 2008
PubMed

Insights

The RNASET2 gene suppresses tumor growth in melanoma models, similar to its role in ovarian cancer. Its anti-tumorigenic activity observed in vivo suggests it acts as a malignancy suppressor gene.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RNASET2 gene, located at 6q27, has shown tumor suppressive functions in ovarian cancer.
  • Understanding the role of RNASET2 in other cancer types is crucial for identifying general tumorigenesis pathways.

Purpose of the Study:

  • To investigate the role of the RNASET2 gene in melanoma tumorigenesis.
  • To determine if RNASET2 exhibits similar anti-tumorigenic activity in melanoma as observed in ovarian cancer models.

Main Methods:

  • Utilized a melanoma cancer model to study RNASET2 gene function.
  • Assessed the in vivo and in vitro activity of RNASET2 in the context of tumorigenesis.

Main Results:

  • RNASET2 demonstrates tumor-suppressive activity in a melanoma cancer model.
  • The anti-tumorigenic effect of RNASET2 is evident in vivo but not in vitro.
  • Data suggests RNASET2 is involved in a general tumorigenesis pathway and acts as a malignancy suppressor gene.

Conclusions:

  • RNASET2 plays a role in controlling tumorigenesis in melanoma, similar to its function in ovarian cancer.
  • The in vivo-specific activity supports the classification of RNASET2 as a tumor-antagonizing/malignancy suppressor gene.
  • The proposed role of RNASET2 in senescence activation appears inconsistent with the current findings.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...